New Weight Loss Drugs Pose Anesthesia Risk, according to Journal of American Physicians and Surgeons
June 06, 2024 13:02 ET
|
Association of American Physicians and Surgeons
Weight loss drugs such as semaglutide impede stomach emptying, creating a significant risk from anesthesia. The effect may last for up to two months
United States Weight Loss Market Status & Forecast Report 2024: $90 Billion Industry Growth Driven by Explosive Sales of GLP-1 Prescription Drugs
May 31, 2024 04:47 ET
|
Research and Markets
Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "The U.S. Weight Loss Market: 2024 Status Report & Forecast" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering.The U.S....
Reddit's Analysis on the Efficacy of FDA Approved Leading Weight Loss Drugs, Q4 2023 - Q2 2024: Focus on Semaglutide, Naltrexone-bupropion, Tirzepatide, Phentermine-topiramate, Liraglutide, Hydrogel
May 14, 2024 10:43 ET
|
Research and Markets
Dublin, May 14, 2024 (GLOBE NEWSWIRE) -- The "Reddit's Analysis on the Efficacy of Leading Weight Loss Drugs" report has been added to ResearchAndMarkets.com's offering.This comprehensive...
Weight Loss Drugs Market Trends Analysis 2018-2023 and Opportunities Forecast 2024-2033 Featuring Pfizer, Roche, Merck & Co, AbbVie, and Novartis
April 24, 2024 04:12 ET
|
Research and Markets
Dublin, April 24, 2024 (GLOBE NEWSWIRE) -- The "Weight Loss Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The weight loss drugs market size has...
Global Weight Loss Drugs Industry Research 2024: Market to Grow at a CAGR of 49.85% to 2029, Driven by Semaglutide (Ozempic and Wegovy), Liraglutide, and Tirzepatide (Marketed as Mounjaroy)
April 23, 2024 05:18 ET
|
Research and Markets
Dublin, April 23, 2024 (GLOBE NEWSWIRE) -- The "Global Weight Loss Drugs Market: Analysis By Product Type, By Drug Type, By Distribution Channel, By End User, By Region, Size and Trends with Impact...
United States Telehealth Weight Loss Market Report 2024: Surge in Telehealth Weight Loss Programs Amidst GLP-1 Medications Boom - Analysis, Forecasts, and Consolidation Insights for 2025
April 17, 2024 03:13 ET
|
Research and Markets
Dublin, April 17, 2024 (GLOBE NEWSWIRE) -- The "The U.S. Telehealth Weight Loss Market" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering The report includes in-depth...
Lexaria Bioscience Corp. (NASDAQ: LEXX) Improves Delivery, Efficacy of GLP-1 Agonists Through Proprietary Drug-Delivery Platform
January 09, 2024 08:30 ET
|
Lexaria Bioscience Corp.
NEW YORK, Jan. 09, 2024 (GLOBE NEWSWIRE) -- via InvestorWire — Lexaria Bioscience Corp. (NASDAQ: LEXX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 60+...
Weight Loss Drugs Market To Attain USD 82.8 Billion By 2032
October 04, 2023 20:10 ET
|
DataHorizzon Research
Fort Collins, Colorado, Oct. 04, 2023 (GLOBE NEWSWIRE) -- DataHorizzon Research published a report titled, "Weight Loss Drugs Market Size, Share Growth, Trends, Statistics Analysis Report By Type...
Weight Loss Drugs Market 2022 | Size, Share, Growth | Market Dynamics, Demand, Key Market Segments, Key Players, Latest Trends, Research Findings, Cost Analysis, Revenue, Price & Gross Margin and Forecast 2029 | Market Reports World
July 07, 2022 07:18 ET
|
Market Reports World
Pune, July 07, 2022 (GLOBE NEWSWIRE) -- Global Weight Loss Drugs Market (2022-2029) research report represents a detailed overview of the current market situation and forecast till 2029. The study...